We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




GE Gets Final Approvals for Instrumentarium Acquisition

By HospiMedica staff writers
Posted on 03 Oct 2003
Print article
The remaining regulatory approvals required for its acquisition of Instrumentarium Corp. (Helsinki, Finland) have been received by GE Medical Systems (Waukesha, WI, USA), according to a GE announcement.

These approvals include those of the US Department of Justice and the Canadian Competition Bureau. The European Commission had previously announced approval. GE's tender offer for all Instrumentarium shares and options is set to expire on September 30, 2003. In order to address issues raised by regulators, GE has agreed to divest the Ziehm surgical C-arm business of Instrumentarium. The company has also reconfirmed its agreement with the European Commission to divest the Spacelabs patient monitoring business and to maintain on a global basis the current practice of GE and Instrumentarium of open interfaces for the products covered by the commitments.

GE states that it will announce the results of the company's tender offer on or about October 6, 2003. If the minimum acceptance level is met, tendering shareholders and option holders will receive payment of the offer price on or about October 14, 2003.





Related Links:
Instrumentarium
GE Medical Systems
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
New
Stereotactic QA Phantom
StereoPHAN
New
Bioengineered Collagen Implant
Tapestry Biointegrative Implant

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.